Kestra Medical (KMTS) CBO adds 227 ESPP shares, now holds 42,488

Rhea-AI Filing Summary

Kestra Medical Technologies Chief Business Officer Timothy P. Moran acquired additional company stock through an employee purchase plan. He obtained 227 shares of common stock on June 30, 2026 at $21.55 per share under the 2025 Employee Stock Purchase Plan for the January 1–June 30, 2026 period. Following this ESPP purchase, he directly holds 42,488 shares of Kestra Medical Technologies common stock, which the disclosure states includes unvested restricted stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Moran Timothy P.

Role Chief Business Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	227	$21.55	$5K

Holdings After Transaction: Common Stock — 42,488 shares (Direct, null)

Footnotes (1)

1. Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026. Includes unvested RSUs.

Key Figures

Shares acquired: 227 shares Transaction price: $21.55 per share Post-transaction holdings: 42,488 shares +2 more

5 metrics

Shares acquired 227 shares Common stock acquired on June 30, 2026 under ESPP

Transaction price $21.55 per share Listed price per share for the ESPP acquisition

Post-transaction holdings 42,488 shares Direct common stock holdings after transaction, includes unvested RSUs

ESPP discount 85% of closing price Purchase price equals 85% of June 29, 2026 closing price

ESPP period January 1–June 30, 2026 Employee Stock Purchase Plan purchase period for these shares

Key Terms

Employee Stock Purchase Plan, ESPP, Rule 16b-3, RSUs

4 terms

Employee Stock Purchase Plan financial

"Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP")"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

ESPP financial

"Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP")"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

Rule 16b-3 regulatory

"in transactions that were exempt under Rule 16b-3, for the ESPP purchase period"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

RSUs financial

"Includes unvested RSUs."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 05:16 PM Accepted by SEC EDGAR 07/02/2026 - 05:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moran Timothy P.

(Last) (First) (Middle)

3933 LAKE WASHINGTON BLVD NE

SUITE 200

(Street)

KIRKLAND WASHINGTON 98033

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026	06/30/2026	A(1)		227	A	$21.55(2)	42,488(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026.

2. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.

3. Includes unvested RSUs.

	/s/ Traci S. Umberger as attorney-in-fact for Timothy P. Moran	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Kestra Medical (KMTS) report for Timothy P. Moran?

Kestra Medical reported that Chief Business Officer Timothy P. Moran acquired 227 shares of common stock. The shares were obtained through the 2025 Employee Stock Purchase Plan for the period from January 1, 2026 through June 30, 2026.

At what price were the Kestra Medical (KMTS) shares acquired in the ESPP transaction?

The reported transaction lists a price of $21.55 per share for the 227 acquired shares. A footnote explains that under the ESPP, the purchase price equals 85% of the closing price of Kestra Medical’s common stock on June 29, 2026.

How many Kestra Medical (KMTS) shares does Timothy P. Moran hold after this Form 4 transaction?

After the transaction, Timothy P. Moran directly holds 42,488 shares of Kestra Medical common stock. The disclosure notes that this figure includes unvested restricted stock units, reflecting both vested and certain unvested equity interests.

What plan was used for Timothy P. Moran’s Kestra Medical (KMTS) share purchase?

The shares were purchased under the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan. The filing states the transaction covered the ESPP purchase period from January 1, 2026 through June 30, 2026 and was exempt under Rule 16b-3.

Was Timothy P. Moran’s Kestra Medical (KMTS) ESPP transaction a market trade?

The transaction was not an open-market trade but a plan-based acquisition. The filing describes it as a purchase under the 2025 Employee Stock Purchase Plan and categorizes it as a grant, award, or other acquisition exempt under Rule 16b-3.